First Online: 11 May 2016
Change Date: 7 June 2016
Change Type: Correction
Change Details: In the original article, the figure given for the number of molecules screened by Eli Lilly was incorrect. The article also wrongly stated that Doug Frantz’s group was the first OIDD contributor to reach an agreement to progress a molecule to animal trials. The text has now been corrected.
Free to read: This content has been made available to all.